‘High Dollar’ Conflicts Should Nullify FDA Advisory Panelists – Public Citizen
This article was originally published in The Tan Sheet
Executive Summary
FDA advisory committee members with large financial conflicts of interest should be recused from meetings in which these conflicts may come into play, Public Citizen recommends after conducting a study on voting patterns